About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

IL-26 and Systemic Lupus Erythematosus

NCT01889641·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Strasbourg, France

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

diagnostic of Lupus according to ACR criteria ( four criteria are necessary)
age \> 18 years old

You may not be if

treatment by cyclophosphamide, rituximab, belimumab in the year before inclusion study

The record

StatusTerminated

PhaseNo phase

Taking part23

StartedFeb 2014

UpdatedSep 8, 2017

Where1

Les Hôpitaux Universitaires de Strasbourg
Strasbourg, Bas Rhin, France

Clareo Health | IL-26 and Systemic Lupus Erythematosus